• Fang, J.Y., Wang, P.W., Huang, C.H., Chen, M.H., Wu, Y.R., Pan, T.L. (2016) Skin aging caused by intrinsic or extrinsic processes characterized with functional proteomics. Proteomics, 16, 2718-2731.
  •  
  • Chen, Y.L., Hwang, T.L., Yu, H.P., Fang, J.Y., Chong, K.Y., Chang, Y.W., Chen, C.Y., Yang, H.W., Chang, W.Y., Hsieh, P.W. (2016) Ilex kaushue and its bioactive component 3,5-dicaffeoylquinic acid protected mice from lipopolysaccharide-induced acute lung injury. Sci. Rep., 6, 34243.
  •  
  • Yu, I.C., Tsai, Y.F., Fang, J.T., Yeh, M.M., Fang, J.Y., Liu, C.Y. (2016) Effects of mouthwash interventions on xerostomia and unstimulated whole saliva flow rate among hemodialysis patients: A randomized controlled study. Int. J. Nurs. Stud., 63, 9-17.
  •  
  • Aljuffali, I.A., Lin, C.F., Chen, C.H., Fang, J.Y.* (2016) The codrug approach for facilitating drug delivery and bioactivity. Expert Opin. Drug Deliv., 13, 1311-1325.
  •  
  • Aljuffali, I.A., Fang, C.L., Chen, C.H., Fang, J.Y.* (2016) Nanomedicine as a strategy for natural compound delivery to prevent and treat cancers. Curr. Pharm. Design, 22, 4219-4231.
  •  
  • Lin, Z.C., Lee, C.W., Tsai, M.H., Ko, H.H., Fang, J.Y., Chiang, Y.C., Liang, C.J., Hsu, L.F., Hu, S.C.S., Yen, F.L. (2016) Eupafolin nanoparticles protect HaCaT keratinocytes from particulate matter-induced inflammation and oxidative stress. Int. J. Nanomed., 11, 3907-3926.
  •  
  • Lin, C.F., Hung, C.F., Aljuffali, I.A., Huang, Y.L., Liao, W.C., Fang, J.Y.* (2016) Methylation and esterification of magnolol for ameliorating cutaneous targeting and therapeutic index by topical application. Pharm. Res., 33, 2152-2167.
  •  
  • Lee, W.R., Shen, S.C., Aljuffali, I.A., Lin, Y.K., Huang, C.W., Fang, J.Y.* (2016) Non-ablative fractional laser assists cutaneous delivery of small- and macro-molecules with minimal bacterial infection risk. Eur. J. Pharm. Sci., 92, 1-10.
  •  
  • Lee, C.W., Lin, Z.C., Hu, S.C.S., Chiang, Y.C., Hsu, L.F., Lin, Y.C., Lee, I.T., Tsai, M.H., Fang, J.Y.* (2016) Urban particulate matter down-regulates filaggrin via COX2 expression/PGE2 production leading to skin barrier dysfunction. Sci. Rep., 6, 27995.
  •  
  • Liu, K.S., Chen, Y.W., Aljuffali, I.A., Chang, C.W., Wang, J.J., Fang, J.Y.* (2016) Topically applied mesoridazine exhibits the strongest cutaneous analgesia and minimized skin disruption among tricyclic antidepressants: the skin absorption assessment. Eur. J. Pharm. Biopharm., 105, 59-68.
  •  
  • Lee, C.W., Lin, Z.C., Hsu, L.F., Fang, J.Y., Chiang, Y.C., Tsai, M.H., Lee, M.H., Li, S.Y., Hu, S.C., Lee, I.T., Yen, F.L. (2016) Eupafolin ameliorate COX-2 expression and PGE2 production in particulate pollutants-exposed human keratinocytes through ROS/MAPKs pathways. J. Ethnopharmacol., 189, 300-309.
  •  
  • Lin, C.H., Chang, S.H., Fang, J.Y.* (2016) Recent advances using phosphodiesterase 4 (PDE4) inhibitors to treat inflammatory disorders: animal and clinical studies. Curr. Drug Ther., 11, 21-40.
  •  
  • Yang, S.C., Aljuffali, I.A., Sung, C.T., Lin, C.F., Fang, J.Y.* (2016) Antimicrobial activity of topically-applied soyaethyl morpholinium ethosulfate micelles against Staphylococcus species. Nanomedicine, 11, 657-671.
  •  
  • Pan, T.L., Wang, P.W., Hung, C.F., Aljuffali, I.A., Dai, Y.S., Fang, J.Y.* (2016) The impact of retinol loading and surface charge on the hepatic delivery of lipid nanoparticles. Colloids Surf. B, 141, 584-594.
  •  
  • Aljuffali, I.A., Lin, Y.K., Fang, J.Y.* (2016) Noninvasive approach for enhancing small interfering RNA delivery percutaneously. Expert Opin. Drug Deliv., 13, 265-280.
  •  
  • Chuang, S.Y., Lin, C.F., Aljuffali, I.A., Fang, J.Y.* (2016) Specific targeting of engineered nanoparticles to activated macrophages. Curr. Nanosci., 12, 63-69.
  •  
  • Fang, Y.P., Yang, S.H., Lee, C.H., Aljuffali, I.A., Kao, H.C., Fang, J.Y.* (2016) What is the discrepancy between drug permeation into/across intact and diseased skins? Atopic dermatitis as a model. Int. J. Pharm., 497, 277-286.
arrow
arrow
    全站熱搜

    Pharmaceutics 發表在 痞客邦 留言(0) 人氣()